Lymphocyte Dysfunctions Associated with Enzyme Defects

  • B. J. M. Zegers
  • L. J. M. Spaapen
  • W. Kuis
  • J. J. Roord
  • G. T. Rijkers
  • J. W. Stoop


Nowadays three heritable molecular defects have been recognized as the primary cause of the associated immune deficiency syndrome. Adenosine deaminase (ADA) deficiency usually is associated with Severe Combined Immunodeficiency (SCID), purine nucleoside phosphorylase (PNP) deficiency is associated with cellular immune deficiency and absence of transcobalamine II (TC II) is associated with agammaglobulinemia (as well as with defects in the cells of the erythropoietic and myelopoietic cell lineage) (1). These causal associations imply the involvement of purine (and pyrimidine) metabolism and of cobalamine in the development and function of the lymphoid system (2). A low activity of another enzyme of the purine metabolic pathway, i.e. ecto-5’-nucleotidase (ecto-5’-NT) has been found in the lymphocytes of patients with hypogammaglobulinemia (3). Meanwhile lymphocytic ecto-5’-NT has been shown to be a marker of the maturation stage of the lymphocytes and low lymphocyte ecto-5’-NT activity in hypogammaglobulinemia may reflect a maturation arrest of the lymphocytes in these patients (2,3). More recently an as yet unexplained association of lymphocytic ecto-5’-NT deficiency with the syndrome of Omenn and concurrent combined immune deficiency has been reported (4).


Severe Combine Immunodeficiency Purine Nucleoside Phosphorylase Enzyme Defect Plaque Form Cell Bony Abnormality 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Enzyme Defects and Immune Dysfunction“, Ciba Symposium 68, Excerpta Medica, Amsterdam, pp. 1–289, (1979).Google Scholar
  2. 2.
    Martin, D.W., Jr., Gelfand, E.W., Ann. Rev. Biochem. 30: 845–877 (1981).CrossRefGoogle Scholar
  3. 3.
    Webster, A.D.E., Clin. Exp. Immunol. 49: 1–10 (1982).PubMedGoogle Scholar
  4. 4.
    Cohen, A., Mansour, A., Dosch, H.M., Gelfand, E.W. Clin. Immunol. Immunopath. 15: 245–250 (1980).CrossRefGoogle Scholar
  5. 5.
    Bach, J.F., Imm. Today 2: 225–227 (1981).CrossRefGoogle Scholar
  6. 6.
    Cowan, M.J., Wara, D., Packman, S., Ammann, A.J., Yoshimo, M., Sweetman, L., Hijhan, W., Lancet 2: 115–118 (1979).PubMedCrossRefGoogle Scholar
  7. 7.
    Fisher, A., Munnich, A., Saudrebray, J.M., Mamas, S., Coude, F.X., Charpentier, C., Dray, F., Frézal, J., Griscelli, C., J. Clin. Immunol. 2: 35–39 (1982).CrossRefGoogle Scholar
  8. 8.
    Hirschhorn, R., Ciba Symposium 68, Excerpta Medica, Amsterdam, pp. 35–49 (1979).Google Scholar
  9. 9.
    Ammann, A., Ciba Symposium 68, Excerpta Medica, Amsterdam, pp. 55–69 (1979).Google Scholar
  10. 10.
    Stoop, J.W., Eijsvogel, V.P., Zegers, B.J.M., Blok-Schut, B., van Bekkum, D.W., Ballieux, R.E., Clin. Immunol. Immunopath. 6: 289–298 (1976).CrossRefGoogle Scholar
  11. 11.
    Stoop, J.W., Zegers, B.J.M., Hendrickx, G.F.M., Siegenbeek van Heukelom, L.H., Stall, G.E.J., de Bree, P.K., Wadman, S.K., Ballieux, R.E., N. Engel. J. Med. 296: 651–655 (1977).CrossRefGoogle Scholar
  12. 12.
    Stoop, J.W., Zegers, B.J.M., Kuis, W., Roord, J.J., Duran, M., Wadman, S.K., Staal, G.E.J., in: “Primary Immunodeficiencies”, Seligmann, M., Hitzig, W.H. (eds.), Elsevier, pp. 301–311 (1980).Google Scholar
  13. 13.
    Watson, A.R., Evans, D.L.K., Mauden, H.B., Miller, V., Rogers, P.A., Arch. Disease of Childhood 56: 563–565 (1981).CrossRefGoogle Scholar
  14. 14.
    Zabay, J.M., de la Concha, E.G., Pascual-Salcedo, D., Subiza, J.L., Lozano, C., Bootello, A., 5th Eur. Immunol. Meeting (1982).Google Scholar
  15. 15.
    Cohen, A., Gudas, L.J., Ulman, B., Martin, D.W., Jr., Ciba Symposium 68, Excerpta Medica, Amsterdam, pp. 101–109, (1979).Google Scholar
  16. 16.
    Watson, A.R., Simmonds, H.A., Webster, D.R., Layward, L., Evans, D.I.K., J. Clin. Chem and Biochem. 20: 431 (1982).Google Scholar
  17. 17.
    Carson, D.A., Kaye, J., Seegmiller, J.E., Proc. Natl. Acad. Soi. USA 74: 5677–5681 (1977).CrossRefGoogle Scholar
  18. 18.
    Kefford, R.M., Fox, R.M., Cancer Res. 42: 324–330 (1982).PubMedGoogle Scholar
  19. 19.
    Carson, D.A., Wasson, D.B., Lakow, E., Kamatani, N., Proc. Natl. Acad. Sci. USA 79: 3438–3852 (1982).CrossRefGoogle Scholar
  20. 20.
    Hershfield, M.S., Kredich, N.M., Ownby, D.R., Ownby, H., Buckley, R., J. Clin. Invest. 63: 807–811 (1979).PubMedCrossRefGoogle Scholar
  21. 21.
    Ochs, U.H., Chen, S.H., Ochs, H.D. Osborne, W.R., Scott, C.R., J. Immunol. 22: 2424–2429 (1979).Google Scholar
  22. 22.
    Hayward, A.R., Clin. Exp. Immunol. 41: 141–149 (1980).PubMedGoogle Scholar
  23. 23.
    Spaapen, L.J.M., Dane, M.E., Toebes, E., Tepas, B., Staal, G.E.J., Duran, M., Kuis, W., Rijkers, G.T., Zegers, B.J.M., Adv. Exp. Med. Biol. (in press).Google Scholar
  24. 24.
    Gelfand, E.W., Lee, J.J., Dosch, H.M., Proc. Natl. Acad. Sci. USA 76: 1998–2002 (1979).PubMedCrossRefGoogle Scholar
  25. 25.
    Heijnen, C.J., UytdeHaag, F., Pot, K.H., Ballieux, R.E., in: “Human B-lymphocyte Function: Activation and Immunoregulation”, Fauci, A.S., Ballieux, R.E. (eds.), Raven Press, pp. 239–253 (1982).Google Scholar
  26. 26.
    Shore, A., Dosch, H.M., Galfand, E.W., Clin. Exp. Immunol. 44: 152–155 (1981).PubMedGoogle Scholar
  27. 27.
    Cohen, A., Lee, J.W.W., Dosch, H.M., Gelfand, E.W., J. Immunol. 125: 1578–1582 (1980).PubMedGoogle Scholar
  28. 28.
    Mitchell, B., Mejias, E., Daddona, P., Kelley, W.N., Proc. Natl. Acad. Sci. USA 75: 5011–5014 (1978).PubMedCrossRefGoogle Scholar
  29. 29.
    North, M.E., Newton, C.A., Webster, A.D.B., Clin. Exp. Immunol. 42: 523–529 (1980).PubMedGoogle Scholar
  30. 30.
    Hirshhorn, R., Roegner-Maniscalco, V., Kuritsky, L., Rosen, F.S., 68, 1387–1393 (1981).Google Scholar
  31. 31.
    Chen, S.H., Ochs, H.D., Scott, C.R., Giblett, E.R., Tingle, A.J., J. Clin. Invest. 62: 1386–1389 (1978).PubMedCrossRefGoogle Scholar
  32. 32.
    Polmar, S.H., Stern, R.C., Schwartz, A.L., Wetzler, E.M., Chase, P.A., Hirschhorn, R., N. Engl. J. Med. 195: 1337–1343 (1976).CrossRefGoogle Scholar
  33. 33.
    Polorar, S.H., in: “Inborn Errors of Specific Immunity”, Pollara, B., Pickering, K.J., Meuwissen, H.J., Porter, I.H. (eds.), Academic Press, New York, pp. 341–351 (1979).Google Scholar
  34. 34.
    Rubinstein, A., Hirschhorn, R., Sicklick, M., Murphy, R.A., N. Engl. J. Med. 300: 387–392 (1979).PubMedCrossRefGoogle Scholar
  35. 35.
    Zegers, B.J.M., Stoop, J.W., Staal, G.E.J., Wadman, S.K., Ciba Symposium 68, Excerpta Medica, Amsterdam, pp. 231–247 (1979).Google Scholar
  36. 36.
    Rich, K.C., Mejias, E., Fox, I.H., N. Engl. J. Med. 303: 973–977 (1980).Google Scholar
  37. 37.
    Rijkers, G.T., Zegers, B.J.M., Spaapen, L.J.M., Rutgers, D.H., Kuis, W., Roord, J.J., Stoop, J.W., Adv. Exp. Med. Biol. (in press).Google Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • B. J. M. Zegers
    • 1
  • L. J. M. Spaapen
    • 1
  • W. Kuis
    • 1
  • J. J. Roord
    • 1
  • G. T. Rijkers
    • 1
  • J. W. Stoop
    • 1
  1. 1.University Children’s HospitalUtrechtThe Netherlands

Personalised recommendations